Literature DB >> 25521408

Two cases of non-small-cell lung cancer with rare complex mutation of EGFR exon 18 but different response to targeted therapy.

Hélène Gauthier1, Gaelle Douchet, Jacqueline Lehmann-Che, Véronique Meignin, Christine Raynaud, Pierre Sabatier, Hubert de Cremoux, Brigitte Poirot, Stéphane Culine, Damien Pouessel, Patricia de Cremoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25521408     DOI： 10.1097/JTO.0000000000000328

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis.

Authors:  Chao Cheng; Rui Wang; Yuan Li; Yunjian Pan; Yang Zhang; Hang Li; Difan Zheng; Shanbo Zheng; Xuxia Shen; Yihua Sun; Haiquan Chen
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

2.  Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.

Authors:  Ming-Ju Tsai; Jen-Yu Hung; Mei-Hsuan Lee; Chia-Yu Kuo; Yu-Chen Tsai; Ying-Ming Tsai; Ta-Chih Liu; Chih-Jen Yang; Ming-Shyan Huang; Inn-Wen Chong
Journal:  Cancers (Basel)       Date:  2018-11-13       Impact factor: 6.639

3.  Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.

Authors:  Coureche Guillaume Kaderbhai; Romain Boidot; Françoise Beltjens; Sandy Chevrier; Laurent Arnould; Laure Favier; Aurélie Lagrange; Bruno Coudert; François Ghiringhelli
Journal:  Oncotarget       Date:  2016-04-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.